N4P.L Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 15:45):

N4 Pharma Plc, a specialist pharmaceutical company, develops novel silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom...

Stats
Tagesvolumen	644 688
Durchschnittsvolumen	759 144
Marktkapitalisierung	2.15M
EPS	£0 ( 2024-04-03 )
Last Dividend	£18.00 ( 1997-05-19 )
Next Dividend	£0 ( N/A )
P/E	-0.800
ATR14	£0.0340 (4.49%)

N4 Pharma PLC Korrelation

10 Am meisten positiv korreliert

10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

N4 Pharma PLC Finanzdaten

Annual	2023
Umsatz:	£1 953.00
Bruttogewinn:	£1 953.00 (100.00 %)
EPS:	£-0.00520

FY	2023
Umsatz:	£1 953.00
Bruttogewinn:	£1 953.00 (100.00 %)
EPS:	£-0.00520

FY	2022
Umsatz:	£0
Bruttogewinn:	£0 (0.00 %)
EPS:	£-0.00550

FY	2021
Umsatz:	£0.00
Bruttogewinn:	£0.00 (0.00 %)
EPS:	£-0.00850

Financial Reports:

No articles found.

N4 Pharma PLC Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)

N4 Pharma PLC Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Information

First Dividend	£16.00	1995-05-22
Last Dividend	£18.00	1997-05-19
Next Dividend	£0	N/A
Payout Date	1997-07-01
Next Payout Date	N/A
# dividends	5	--
Total Paid Out	£85.20	--
Avg. Dividend % Per Year	0.00%	--
Score	1.05	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-10-21)

£0 Estimate 0.00 %

Dividend Stability

0.01 Very Bad

Dividend Score

1.05

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield
1995	£0	0.00%
1996	£0	0.00%
1997	£0	0.00%
1998	£0	0.00%
1999	£0	0.00%
2000	£0	0.00%
2001	£0	0.00%
2002	£0	0.00%
2003	£0	0.00%
2004	£0	0.00%
2005	£0	0.00%
2006	£0	0.00%
2007	£0	0.00%
2008	£0	0.00%
2009	£0	0.00%
2010	£0	0.00%
2011	£0	0.00%
2012	£0	0.00%
2013	£0	0.00%
2014	£0	0.00%
2015	£0	0.00%
2016	£0	0.00%
2017	£0	0.00%
2018	£0	0.00%
2019	£0	0.00%
2020	£0	0.00%
2021	£0	0.00%
2022	£0	0.00%
2023	£0	0.00%
2024	£0	0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for LSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
WTB.L	Dividend Knight	2023-05-25	Annually	33	0.87%
NTV.L	Dividend Knight	2023-07-20	Semi-Annually	25	4.03%
EMG.L	Dividend King	2023-08-10	Semi-Annually	31	3.60%
SPT.L	Dividend Knight	2023-08-10	Semi-Annually	32	1.51%
JD.L	Dividend Knight	2023-12-07	Annually	28	0.21%
BUT.L	Dividend King	2023-08-03	Quarterly	49	1.28%
PNL.L	Dividend Knight	2023-08-24	Quarterly	41	0.75%
FSFL.L	Dividend Knight	2023-07-20	Quarterly	11	3.85%
AERI.L	Dividend Junior	2023-08-17	Quarterly	6	2.80%
THRG.L	Dividend Knight	2023-08-03	Semi-Annually	52	1.02%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-649.94	1.500	-10.00	-10.00	[0 - 0.5]
returnOnAssetsTTM	-0.995	1.200	-10.00	-10.00	[0 - 0.3]
returnOnEquityTTM	-0.987	1.500	-10.00	-10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	14.86	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	14.73	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	12.57	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	-0.00478	2.00	-0.00159	-0.00318	[0 - 30]
freeCashFlowPerShareTTM	-0.00478	2.00	-0.00239	-0.00478	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	1.000	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	-729.44	1.000	-10.00	-10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0.00153	0.800	-3.32	-2.66	[0.5 - 2]
Total Score				-1.289

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-1.545	1.000	-0.257	0	[1 - 100]
returnOnEquityTTM	-0.987	2.50	-7.76	-10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.00478	2.00	-0.00159	-0.00478	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.00478	2.00	-0.00159	-0.00318	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.883	1.500	-9.22	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-619.10	1.000	-10.00	0	[0.1 - 0.5]
Total Score				-3.03

N4 Pharma PLC

N4 Pharma Plc, a specialist pharmaceutical company, develops novel silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.